7 Dyslipidaemia and obesity

Bailliere's Clinical Endocrinology and Metabolism

Volumn 8, Issue 3, 1994, Pages 629-660

  Després, Jean Pierre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FENFLURAMINE; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANTHROPOMETRY; BODY FAT; CALORIC RESTRICTION; COMPUTER ASSISTED TOMOGRAPHY; DIET; DYSLIPIDEMIA; EXERCISE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; METABOLISM; OBESITY; REVIEW; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; VISCERA;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; CORONARY DISEASE; DIET; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; OBESITY; SUPPORT, NON-U.S. GOV'T;

EID: 0027980920     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(05)80289-7     Document Type: Article

References (158)

1. Interrelationship between skinfold thickness, serum lipids and blood sugar in normal men
2. Serum lipids: an epidemiological study of an active Montreal population
3. Position stand on the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults
4. Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patients
5. Body fat distribution, plasma lipids and lipoproteins
6. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein cholesterol
7. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography
8. Low density lipoprotein subclass patterns and risk of myocardial infarction
9. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
10. Obesity, atherosclerosis, and coronary artery disease
11. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin
12. Hazards in subgroups of human obesity
13. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus
14. How obesity should be defined?
15. ‘Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
16. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease?
17. Metabolic implications of body fat distribution
18. The effect of physical training on insulin production in obesity
19. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis
20. Assessment of abdominal fat content by computed tomography
21. Variation in fat distribution with age and health implications
22. The response to long-term overfeeding in identical twins
23. Exercise and Obesity
24. Complications of obesity
25. Treatment of obesity; an overview
26. Metabolic approaches to atherosclerosis: effect of gliclazide
27. Neuroendocrine regulation and obesity
28. Possible connections between stress, diabetes, obesity, hypertension, and altered metabolism that may result in atherosclerosis
29. A receptor-mediated pathway for cholesterol homeostasis
30. Effects of fenfluramine in hypertriglyceridemic obese subjects
31. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man
32. Heterogeneity of primary lipoprotein lipase deficiency
33. Low density lipoprotein particle size and coronary artery disease
34. Final report
35. Epidemiology of coronary heart disease: the Framingham Study
36. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
37. Obesity and lipid metabolism: relevance of body fat distribution
38. Visceral obesity, insulin resistance, and related dyslipoproteinemias
39. Lipoprotein metabolism in visceral obesity.
40. Obesity, regional adipose tissue distribution and metabolism: effect of exercise
41. Assessing obesity: beyond the BMI
42. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
43. Abdominal obesity as important component of insulin-resistance syndrome
44. Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease
45. Evidence for a regional component of body fatness in the association with serum lipids in men and women
46. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women
47. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women
48. Adipose tissue distribution and plasma lipoprotein levels in obese women: Importance of intra-abdominal fat
49. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL-cholesterol in obese women
50. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
51. Long-term exercise training with constant energy intake. 3. Effects on plasma lipoprotein levels
52. Correlates of plasma very-low-density lipoprotein concentration and composition in premenopausal women
53. Loss of abdominal fat and metabolic response to exercise training in obese women
54. Estimation of deep abdominal fat accumulation from simple anthropometric measurements in men
55. Genetic aspects of susceptibility to obesity and related dyslipidemias
56. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia
57. Central obesity and coronary heart disease in men
58. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study
59. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes
60. Adipose tissue lipoprotein lipase
61. Lipoprotein lipase. A multifactorial enzyme relevant to common metabolic diseases
62. Weight reduction increases adipose tissue lipoprotein lipase responsiveness in obese women
63. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography
64. Health implications of obesity: an alternative view
65. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women
66. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements
67. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome
68. Insulin resistance: a secret killer
69. Insulin resistance and lipid metabolism
70. Insulin resistance, adipose tissue and coronary heart disease
71. Relationship of absence or presence of a family history of diabetes to body weight and body fat distribution in type 2 diabetes
72. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity
73. Treatment of visceral obesity
74. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal with visceral fat obesity
75. Beneficial health effects of modest weight loss
76. Quantitation of body fat distribution in the abdomen using computed tomography
77. Long term pharmacotherapy in the management of obesity: from theory to practice
78. International trial of long-term dexfenfluramine in obesity
79. Clinical features and pathophysiology of familial dyslipidemic hypertension syndrome
80. Height—weight tables
81. Alterations in low-density lipoproteins in subjects with abdominal adiposity
82. Lipoprotein metabolism in diabetes mellitus
83. Indices of relative weight and obesity
84. Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action
85. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus
86. Inter-relationships between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (Phenformin)
87. Relation of body fat distribution to metabolic complications of obesity
88. Endocrine characteristics in regional obesities: role of sex steroids
89. Health risks of obesity
90. The tangled web of coronary risk factors
91. Muscle tissue in obesity with different distribution of adipose tissue: effects of physical training
92. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution
93. Prevalence of overweight and weight gain in the United States
94. Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following aerobic exercise training in obese women?
95. Effect of exercise training on glucose tolerance, insulin sensitivity, lipid and lipoprotein concentration in middle-aged men with mild hyperglyceridemia
96. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
97. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
98. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden
99. Obesity, fat distribution and cardiovascular disease
100. The health consequences of moderate obesity
101. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913
102. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations
103. Visceral fat accumulation in obese subjects: relation to energy expenditure and response to weight loss
104. Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women
105. Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women
106. Heterogeneous glycaemic and insulinaemic responses to oral glucose in non-diabetic men: interactions between duration of obesity, body fat distribution and family history of diabetes mellitus
107. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness
108. Genetic factors affecting blood lipoproteins: the candidate gene approach
109. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
110. Postprandial hyperlipidemia: the search for the atherogenic lipoprotein
111. Health Implications of Obesity
112. Lowering cholesterol to prevent heart disease
113. Specific assays for lipoprotein lipase and hepatic lipase activities in postheparin plasma
114. Changes in high density lipoprotein subfractions and other lipoproteins induced by exercise
115. The influence of body fat distribution on the incidence of diabetes mellitus—13.5 years of follow-up of the participants in the study of men born in 1913
116. 2
117. Reappraisal of the role of insulin in hypertriglyceridemia
118. 2 cholesterol level in older adults
119. 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase
120. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women
121. Adiposity, fat distribution, and cardiovascular risk
122. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women
123. Fenfluramine increases insulin action in patients with NIDDM
124. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women
125. Regional variation in adipose tissue lipoprotein lipase activity: association with plasma high density lipoprotein levels
126. Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels
127. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
128. Effect of moderate exercise on serum lipids in young men with low high density lipoprotein cholesterol levels
129. Influence of moderate exercise on glucose homeostasis and serum testosterone in young men with low HDL-cholesterol levels
130. Role of insulin resistance in human disease
131. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease
132. The role of insulin resistance and hyperinsulinemia in coronary heart disease
133. Glucocorticoid binding of human adipose tissue
134. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation
135. Regional adipose tissue metabolism in men and post-menopausal women
136. Obesity and its relation to cardiovascular disease risk factors in Canadian adults
137. Lipoprotein lipase activity in muscle tissue influenced by fatness, fat distribution and insulin in obese females
138. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique
139. Mechanism of action of gemfibrozil on lipoprotein metabolism
140. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine
141. The effect of intensive endurance training on body fat distribution in young and older men
142. Assessment of intra-abdominal and subcutaneous abdominal fat: relation between anthropometry and computed tomography
143. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex and age
144. Visceral fat accumulation is positively associated with insulin, glucose and c-peptide levels, but negatively with testosterone levels
145. 40K, and tritium
146. Relationship of body fat distribution to glucose tolerance. Results of computed tomography in male participants of the normative aging study
147. Hyperinsulinemia and hypertriglyceridemia. A vicious cycle with atherogenic potential
148. The independent contributions of various indices of obesity to the 22-year incidence of coronary heart disease: the Framingham heart study
149. Regional adiposity pattern in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men
150. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat
151. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US army veterans during a twenty-three year follow-up study
152. A novel technique for the determination of body fat by computed tomography
153. Normalization of the metabolic profile in obese women by exercise and a low fat diet
154. La différenciation sexuelle, facteur déterminant des formes de l'obésité
155. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric-calculous disease
156. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men
157. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise